Compare DSX & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSX | TKNO |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.7M | 268.1M |
| IPO Year | 2005 | 2021 |
| Metric | DSX | TKNO |
|---|---|---|
| Price | $3.00 | $8.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 153.2K |
| Earning Date | 05-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | $14.28 | $8.27 |
| Revenue Next Year | $4.87 | $13.13 |
| P/E Ratio | $16.02 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $1.57 | $1.91 |
| 52 Week High | $3.20 | $7.92 |
| Indicator | DSX | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 63.16 | 71.40 |
| Support Level | $2.29 | $3.33 |
| Resistance Level | $3.09 | N/A |
| Average True Range (ATR) | 0.11 | 0.43 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 58.00 | 99.18 |
Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize, and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods, including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers, through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation; the services provided by the vessels are similar, and all operate under the same economic environment.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.